Stockreport

Eli Lilly cuts Zepbound price to widen access for obesity drug [Yahoo! Finance]

Eli Lilly and Company  (LLY) 
Last eli lilly and company earnings: 4/23 06:25 am Check Earnings Report
US:NYSE Investor Relations: investor.lilly.com
PDF Dec 1 (Reuters) - Eli Lilly said on Monday it has lowered the price of single-dose vials of its popular ?obesity drug Zepbound to make the treatment more affordable for [Read more]